设为首页 加入收藏

TOP

TEPADINA 15 mg powder for concentrate for solution for infusion(七)
2018-01-24 02:34:52 来源: 作者: 【 】 浏览:7948次 评论:0
ceived thiotepa for conditioning treatment prior to haematopoietic progenitor cell transplantation.
Serious toxicities involving the haematologic, hepatic and respiratory systems were considered as expected consequences of the conditioning regimen and transplant process. These include infection and Graft-versus host disease (GvHD) which, although not directly related, were the major causes of morbidity and mortality, especially in allogeneic HPCT.
The most frequently adverse reactions reported in the different conditioning treatments including thiotepa are: infections, cytopenia, acute GvHD and chronic GvHD, gastrointestinal disorders, haemorrhagic cystitis, mucosal inflammation.
Leukoencephalopathy
Cases of leukoencephalopathy have been observed following treatment with thiotepa in adult and paediatric patients with multiple previous chemotherapies, including methotrexate and radiotherapy. Some cases had a fatal outcome.
Tabulated list of adverse reactions
Adults
The adverse reactions considered at least possibly related to conditioning treatment including thiotepa, reported in adult patients as more than an isolated case, are listed below by system organ class and by frequency. Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness. Frequencies are defined as: very common (≥1/10), common (≥1/100 to <1/10), uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000) very rare (<1/10,000), not known (cannot be estimated from the available data).
System organ class
 Very common
 Common
 Uncommon
 Not known
Infections and infestations
 Infection susceptibility increased
Sepsis
 Toxic shock syndrome
Neoplasms benign, malignant and unspecified (incl cysts and polyps)
 Treatment related second malignancy
Blood and lymphatic system disorders
 Leukopenia
Thrombocytopenia
Febrile neutropenia
Anaemia
Pancytopenia
Granulocytopeni
Immune system disorders
 Acute graft versus host disease
Chronic graft versus host disease
 Hypersensitivity
Endocrine disorders
 Hypopituitarism
Metabolism and nutrition disorders
 Anorexia
Decreased appetite
Hyperglycaemia
Psychiatric disorders
 Confusional state
Mental status changes
 Anxiety
 Delirium
Nervousness
Hallucination
Agitation
Nervous system disorders
 Dizziness
Headache
Vision blurred
Encephalopathy
Convulsion
Paraesthesia
 Intracranial aneurysm
Extrapyramidal disorder
Cognitive disorder
Cerebral haemorrhage
 Leukoencephalopathy
Eye disorders
 Conjunctivitis
 Cataract
Ear and labyrinth disorders
 Hearing impaired
Ototoxicity
Tinnitus
Cardiac disorders
 Arrhythmia
 Tachycardia
Cardiac failure
 Cardiomyopathy
Myocarditis
Vascular disorders
 Lymphoedema
Hypertension
 Haemorrhage
Embolism
Respiratory, thoracic and mediastinal disorders
 Idiopathic pneumonia syndrome
Epistaxis
 Pulmonary oedema
Cough
Pneumonitis
 Hypoxia
Gastrointestinal disorders
 Nausea
Stomatitis
Oesophagitis
Vomiting
Diarrhoea
Dyspepsia
Abdominal pain
Enteritis
Colitis
 Constipation
Gastroint
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 4 5 6 7 8 9 10 下一页 尾页 7/13/13
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇INCIVO*FL 168CPR RIV 375MG 下一篇TEPADINA 100 mg powder for conc..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位